ROSEN TERRY J sold ~$629K in Arcus Biosciences, Inc. stock
Arcus Biosciences, Inc. (RCUS) · Chief Executive Officer · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
+25.4%vs SPY +8.1%
Trade Details · Public SEC Filing
Insider
ROSEN TERRY J
Role
Chief Executive Officer
Transaction
Open-Market Sale
Approx. Value
~$629K
Trade Date
Jun 16, 2022
Company
Arcus Biosciences, Inc.
Ticker
RCUSSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$629K sale
A significant position. Insiders who invest $500K+ of their own money typically have strong views on their company's near-term outlook.
Chief Executive Officer
CEOs have the deepest knowledge of company operations. Academic research shows CEO purchases outperform other insider trades by a wide margin.
4 insiders traded in the same window
When multiple insiders independently buy within 30 days, it's called a cluster. Studies show clustered insider purchases outperform solo trades significantly, because several people with inside knowledge are reaching the same conclusion.
+25.4% in 90 days (S&P 500: +8.1%)
This trade beat the S&P 500 by 17.3 percentage points over 90 days. We track performance on every insider trade so you can see who consistently outperforms.
How good is ROSEN TERRY J at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
ROSEN TERRY J wasn't the only one selling.
4 insiders at Arcus Biosciences, Inc. traded within the same 30-day window.
See who else bought · FreeOn June 16, 2022, ROSEN TERRY J — Chief Executive Officer of Arcus Biosciences, Inc. — filed a Form 4 with the SEC disclosing an open-market sale of approximately ~$629K in Arcus Biosciences, Inc. (RCUS) stock.
This transaction was part of a cluster — 4 insiders at Arcus Biosciences, Inc. made open-market sales within the same 30-day window. Cluster activity from multiple independent insiders is one of the most studied patterns in insider trading research.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, RCUS returned +25.4% versus +8.1% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time ROSEN TERRY J trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More RCUS Insider Activity
ROSEN TERRY J
Dec 17, 2025
~$2.9M
STRONG
ROSEN TERRY J
Dec 16, 2025
~$3.0M
STRONG
ROSEN TERRY J
Feb 18, 2025
~$15M
VS
ROSEN TERRY J
Dec 16, 2022
~$1.2M
STRONG
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free